NCT00634829View on ClinicalTrials.gov

Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction

PHASE3TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
AsthmaBronchospasm
Interventions
DRUG

albuterol (Armstrong Albuterol HFA)

2 inhalations of 108 mcg albuterol sulfate prior to exercise, single dose

DRUG

Albuterol Sulfate (Provenetil-HFA)

2 inhalations of Proventil-HFA, 108 mcg/inhalation prior to exercise

DRUG

Placebo-HFA

Placebo containing HFA propellant without active drug substance

Trial Locations (3)

80112

Colorado Allergy and Asthma Center, Englewood

80230

Colorado Allergy and Asthma Center, Denver

80401

Colorado Allergy and Asthma Center, Lakewood

Sponsors
All Listed Sponsors
lead

Amphastar Pharmaceuticals, Inc.

INDUSTRY